Cancer Immunotherapy Market Size, Share, By Product Type (Monoclonal Antibodies, Immunomodulators, Checkpoint Inhibitors, Adoptive Cell Therapy, and Others), By Cancer Type (Lung Cancer, Colorectal Cancer, Melanoma, Breast Cancer, Head & Neck Cancer, Prostate Cancer, and Others), By End User (Hospitals, Cancer Research Centers, and Others), and By Region - Trends, Analysis and Forecast till 2034

Personalized Medicine:

• Advances in genomics and immunology are advancing toward fully realizing the dream of personalized cancer immunotherapy. Such patient-derived tumor and immune system profiling could help tailor the treatment regimen for an optimum outcome. This route to new, precise medications would yield effective and good targeting. Thus, it would improve patient response rates and reduce the toxicity profile.